
Widow Speaks Out on Long-delayed COVID Injury Claims
The focus of the [Countermeasures Injury Compensation Program] right now is to help reimburse people impacted by COVID-related treatments. There are more than 13,000 claims from
The focus of the [Countermeasures Injury Compensation Program] right now is to help reimburse people impacted by COVID-related treatments. There are more than 13,000 claims from
A new population-based study conducted by researchers at Harvard-affiliated Mass General Brigham has found that cardiac deaths have increased significantly since the onset of the
Two years have passed since the official end of the Covid-19 pandemic, yet the topic of vaccination remains highly sensitive in both public and scientific
On May 20, 2025, the U.S. Food and Drug Administration (FDA) announced that new clinical trials will be required to approve annual COVID-19 booster shots
On May 30, 2025, the U.S. Food and Drug Administration (FDA) licensed mNEXSPIKE (mRNA-1283), a newly developed mRNA COVID-19 biologic for individuals who have previously
Moderna, Inc. withdrew its application for United States licensure for its combination COVID-19/Influenza vaccine known as mRNA-1083. The company stated the decision came “in consultation